(Q77579314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

title

Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

Robert William Schrier

series ordinal

2

object named as

R W Schrier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

R O Estacio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

9B

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

9R-14R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Cause-specific mortality in a population-based study of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

The management of chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Angiotensin-converting enzyme inhibition in type I diabetic nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

The risk of myocardial infarction associated with antihypertensive drug therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Prospective study of calcium channel blocker use, cardiovascular disease, and total mortality among hypertensive women: the Nurses' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

The calcium antagonist controversy: the emerging importance of drug formulation as a determinant of risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Nisoldipine versus isosorbide dinitrate in coronary heart disease: results of a double-masked study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

The integrated effects of angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

The renin-angiotensin system and fibrinolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

Protective action of calcium channel antagonists in atherogenesis and experimental vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900750-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(98)00750-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9822137%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference